August 23, 2018
Rose
How to fit these therapies, that are innovative yet extremely expensive, into Medicare's payment model leaves advisers more confused than anything. In other pharmaceutical news, a curtain is pulled back on the drug development process and scientists look to create a new class of drugs to treat malaria.
from Kaiser Health News https://ift.tt/2LnphzT
August 23, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Candidates Tap Into Constituents’ Personal Struggles With Opioids To Woo Voters- Michigan’s Medicaid Work Requirement Advances On Expected Path To Approval
- Listen: What You Need To Know About The News On Breast Cancer And Chemo
- ‘Right-To-Try’ May Now Be Law Of The Land, But That Doesn’t Mean Companies Will Start Offering Up Their Drugs
- First Edition: June 7, 2018
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment